Search

everythinglearnresearchcommunity

for

Search:↓

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Forehead rejuvenation is key to facial rejuvenation, with various surgical techniques tailored to individual needs.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The transtemporal midface lift improves the lower eyelid and cheek area with high patient satisfaction and low complication rates.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

The gel effectively thickens eyelashes and eyebrows without side effects.

Punch grafting is useful for restoring hair to the inner eyebrow area after certain surgeries.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.